Evaluation of Exposure Reduction Using Region-of-Interest Fluoroscopy (X-ray Fovea Imaging) in Cardiac Interventions
Trial to Determine Non-inferiority of Exposure Dose Reduction and Diagnostic Performance of Region-of-Interest Fluoroscopy (X-ray Fovea Imaging) Compared to Standard Fluoroscopy in Patients Undergoing Cardiac Interventional Procedures
1 other identifier
interventional
75
1 country
1
Brief Summary
The aim of the proposed study is to compare the exposure dose and diagnostic performance of region-of-interest fluoroscopy compared to standard fluoroscopy in patients and interventionists during cardiac interventional procedures. It is hypothesized that systematic application of x-ray attenuation will significantly reduce the radiation exposure of the interventional procedure while maintaining image quality, thereby decreasing risk to the patient.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1 cardiovascular-diseases
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 14, 2008
CompletedFirst Posted
Study publicly available on registry
January 6, 2009
CompletedStudy Start
First participant enrolled
February 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2009
CompletedAugust 7, 2009
January 1, 2009
10 months
November 14, 2008
August 6, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
X-ray exposure area product, primary and scatter radiation to patient and interventionist and procedure and irradiation time for interventions performed without and with region-of-interest imaging (control and experimental arms, respectively).
The outcome measure will be recorded per patient procedure. A comparison between control and experimental arms will be conducted after the pilot study (at ~1 to 2 months) and at end the full study (at ~4 to 6 months).
Secondary Outcomes (1)
Quality and diagnostic benefit of images obtained without and with the region-of-interest imaging.
Retrospective expert comparison of images from patient procedures (between control and experimental arms) will occur within 1 to 3 months after the completion of the pilot study and the full study.
Study Arms (2)
1
NO INTERVENTIONSubjects undergoing routine cardiac catheterization or interventional procedures using the standard fluoroscopy system.
2
EXPERIMENTALSubjects undergoing routine cardiac catheterization or interventional procedures using the region-of-interest fluoroscopy (x-ray fovea imaging) system.
Interventions
Use of an experimental fluoroscopy system fitted with a region-of-interest attenuator (fovea) to evaluate or treat lesions during cardiac interventional procedures.
Eligibility Criteria
You may qualify if:
- The subject is greater than 18 years of age.
- The subject is currently planned for conventional cardiac interventional procedures (i.e. catheterization, percutaneous coronary intervention (PCI), electrophysiology (EP) ablations and procedures) as specified by his/her physician.
- The subject is able and willing to comply with study procedures, and signed and dated informed consent is obtained.
You may not qualify if:
- The subject is pregnant or trying to become pregnant.
- The subject requires urgent/emergent cardiac catheterization, PCI, and/or EP procedures as per treating physician.
- The subject has been previously included in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sunnybrook Health Sciences Centrelead
- General Electriccollaborator
Study Sites (1)
Sunnybrook Health Sciences Centre
Toronto, Ontario, M4N 3M5, Canada
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Alexander J Dick, MD
Sunnybrook Health Sciences Centre
- STUDY DIRECTOR
Normand Robert, PhD
Sunnybrook Health Sciences Centre
- STUDY CHAIR
John A Rowlands, PhD
Sunnybrook Health Sciences Centre
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
November 14, 2008
First Posted
January 6, 2009
Study Start
February 1, 2009
Primary Completion
December 1, 2009
Last Updated
August 7, 2009
Record last verified: 2009-01